Structured evidence table for Resistant Starch Insulin Sensitivity Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Resistant Starch Insulin Sensitivity Randomized Trial | Evidence has emerged that HAS can alter the gut microbial profile and composition by enhancing the proliferation of beneficial bacteria. | 3 | Suzauddula Md (2026) | High-Amylose Starch and Human Health: Microbiota Modulation, Metabolic Reprogramming, and Disease Prevention |
| Resistant Starch Insulin Sensitivity Randomized Trial | Such alteration of beneficial microorganisms is already known to be positively associated with gut health and reduced inflammation [,]. | 3 | Suzauddula Md (2026) | High-Amylose Starch and Human Health: Microbiota Modulation, Metabolic Reprogramming, and Disease Prevention |
| Resistant Starch Insulin Sensitivity Randomized Trial | Overall, the present review is distinct from previous publications by focusing on HAS as a microbiome-active dietary component and by integrating evidence across gut microbial remodeling, microbial metabolite production, gut barrier function, inflammation, and disease-relevant outcomes. | 3 | Suzauddula Md (2026) | High-Amylose Starch and Human Health: Microbiota Modulation, Metabolic Reprogramming, and Disease Prevention |
| Resistant Starch Insulin Sensitivity Randomized Trial | 1 2 3 4 5 6 7 8 9 Resistant starch (RS) is a type of starch that resists digestion in the small intestine and reaches the colon. | 3 | Suzauddula Md (2026) | High-Amylose Starch and Human Health: Microbiota Modulation, Metabolic Reprogramming, and Disease Prevention |
| Resistant Starch Insulin Sensitivity Randomized Trial | Purpose of review Resistant starch (RS) has been widely investigated as a dietary component with potential metabolic benefits, including improved insulin sensitivity, lipid profile, and inflammatory markers. | 4 | Tavares IRG (2026) | Resistant Starch as a Functional Nutrient to Control Cardiometabolic Risk Factors in Humans: An Integrative Review. |
| Resistant Starch Insulin Sensitivity Randomized Trial | This integrative review aimed to synthesize evidence on the effects of RS consumption in dietary interventions on metabolic and cardiovascular parameters in adults and older adults. | 4 | Tavares IRG (2026) | Resistant Starch as a Functional Nutrient to Control Cardiometabolic Risk Factors in Humans: An Integrative Review. |
| Resistant Starch Insulin Sensitivity Randomized Trial | Recent findings RS intake, particularly RS2 and RS3, was associated with significant reductions in postprandial glucose, insulin, and HOMA-IR, as well as improvements in total cholesterol, LDL-C, and triglycerides. | 4 | Tavares IRG (2026) | Resistant Starch as a Functional Nutrient to Control Cardiometabolic Risk Factors in Humans: An Integrative Review. |
| Resistant Starch Insulin Sensitivity Randomized Trial | However, clinical findings remain inconsistent, particularly regarding RS type and dosage. | 4 | Tavares IRG (2026) | Resistant Starch as a Functional Nutrient to Control Cardiometabolic Risk Factors in Humans: An Integrative Review. |
Source documents